Product Information
ZOLPIDEM TARTRATE 10 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0396 per EA under NDC 65862016099. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on May 4, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862016099
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA078413FDA Approved
5/4/2007
TE Code
AB
On Market Since
5/4/2007
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has been published 131 times since Apr 3, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0396 per EA |
|---|---|
| All-time high | $0.0398 (Apr 10, 2024) |
| All-time low | $0.0267 (Nov 20, 2024) |
| 52-week high | $0.0396 |
| 52-week low | $0.0377 |
| Median price | $0.0381 |
| Average price | $0.0368 |
| Largest weekly change | -29.0% (Nov 20, 2024) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 32% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolpidem Tartrate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
gamma-Aminobutyric Acid-ergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLPIDEM TARTRATE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TARTRATE 10 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0396 per EA (NDC 65862016099), effective Sep 30, 2026.
How has the price of ZOLPIDEM TARTRATE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has held within roughly two percent of its current level. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TARTRATE 10 MG TABLET?
Since Apr 3, 2024, the NADAC for ZOLPIDEM TARTRATE 10 MG TABLET has ranged from a low of $0.0267 (Nov 20, 2024) to a high of $0.0398 (Apr 10, 2024), with a median of $0.0381 per EA.
Are there cheaper alternatives to ZOLPIDEM TARTRATE 10 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLPIDEM TARTRATE 10 MG TABLET, is $0.0271 per EA — about 32% below ZOLPIDEM TARTRATE 10 MG TABLET.
Who manufactures ZOLPIDEM TARTRATE 10 MG TABLET?
ZOLPIDEM TARTRATE 10 MG TABLET (NDC 65862016099) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.